NCOA1–ALK: a novel ALK rearrangement in one lung adenocarcinoma patient responding to crizotinib treatment
Qi Cao,1 Zhiguang Liu,1 Yanhua Huang,1 Chuang Qi,2 Xiaowei Yin1 1Department of Respiratory and Critical Care Medicine, Changzhou Second Affiliated People’s Hospital of Nanjing Medical University, Changzhou 213003, China; 2Medical Department, 3D Medicines, Shanghai 201100, China Abstract:...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2019-02-01
|
| Series: | OncoTargets and Therapy |
| Subjects: | |
| Online Access: | https://www.dovepress.com/ncoa1ndashalk-a-novel-alk-rearrangement-in-one-lung-adenocarcinoma-pat-peer-reviewed-article-OTT |